Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Number of Treatment Emergent Adverse Events (AEs) by Severity

Number of mild, moderate, and severe AEs (mild = does not interfere with subject's usual function; moderate = interferes to some extent with subject's usual function; severe = interferes significantly with subject's usual function)

Time frame: Baseline up to 24 months

Number of Participants With Brain Abnormalities in Magnetic Resonance Imaging (MRI) Data

Number of participants with brain abnormalities in MRI data that are either consistent or not consistent with AD, as determined by radiologists.

Time frame: Baseline up to 24 months

Number of Participants With Abnormalities in Neurological Examination

Number of participants with abnormalities in neurological examinations as determined by the investigators. Neurological examinations included Mental Status, Speech, Cranial Nerve Function, Cranial Nerve II, Sensory Function, Motor Function, Coordination, Gait and Station, Reflexes and Deep Tendon Reflexes.

Time frame: Baseline of the preceding studies through 24 months of this study